Mexiletine - channeling ALS? - a podcast by ALS Today, ALS Therapy Development Institute
from 2013-02-05T01:00
::
::
Michael Weiss MD, Director of the Neuromuscular Diseases Division of the University of Washington School of Medicine, discusses an upcoming phase II clinical trial that puts mexiletine to the test in ALS, a potential early treatment of the disease. Read more: http://blogs.als.net/post/2013/02/05/Mexiletine-channeling-ALS.aspx
Further episodes of ALS Today Audio Podcasts
Further podcasts by ALS Today, ALS Therapy Development Institute
Website of ALS Today, ALS Therapy Development Institute